Formulation and evaluation of fast disintegrating tablet of glimepiride
Glimepiride is the third generation sulphonylurea agent, used for the treatment of type II diabetes mellitus. Glimepiride is given once daily in doses from 1-4 mg. The objective of the present study was to formulate and evaluate the fast disintegrating tablets of Glimepiride. Method: The fast disso...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AMMANIF
2018-07-01
|
| Series: | Journal of Contemporary Pharmacy |
| Subjects: | |
| Online Access: | https://ammanif.com/journal/jcp/index.php/home/article/view/13 |